Search

Author/Creator Seko, Noriko

1. Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients. Issue 1 (2nd January 2021)

Authors:
Nishimura, Kenichi; Hara, Ryoki; Umebayashi, Hiroaki; Takei, Syuji; Iwata, Naomi; Imagawa, Tomoyuki; Shimizu, Masaki; Tomiita, Minako; Seko, Noriko; Kitawaki, Tetsuji; Yokota, Shumpei
Journal:
Modern rheumatology
Issue:
Volume 31:Issue 1(2021)
Page Start:
226
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52‐week analysis from phase III open‐label multicenter Japanese study. Issue 9 (26th February 2016)

Authors:
Imafuku, Shinichi; Honma, Masaru; Okubo, Yukari; Komine, Mayumi; Ohtsuki, Mamitaro; Morita, Akimichi; Seko, Noriko; Kawashima, Naoko; Ito, Saori; Shima, Tomohiro; Nakagawa, Hidemi
Journal:
Journal of dermatology
Issue:
Volume 43:Issue 9(2016)
Page Start:
1011
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Secukinumab efficacy and safety in Japanese patients with moderate‐to‐severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo‐controlled, phase 3 study. Issue 12 (30th October 2014)

Authors:
Ohtsuki, Mamitaro; Morita, Akimichi; Abe, Masatoshi; Takahashi, Hidetoshi; Seko, Noriko; Karpov, Alexander; Shima, Tomohiro; Papavassilis, Charis; Nakagawa, Hidemi; the ERASURE Study Japanese subgroup
Journal:
Journal of dermatology
Issue:
Volume 41:Issue 12(2014)
Page Start:
1039
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗